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June Supplement 201042S Abstractslar disease. The aim of this meta-analysis is to assess the
effect of the combination of ASA/plavix compared with
ASA alone in the prevention of stoke in patients with
symptomatic cardiovascular disease.
Methods: A systematic search of randomized con-
trolled trials reporting treatment of cardiovascular disease
with antiplatelet agents was performed. Statistical analysis
was performed using the commercially available software
CMAVersion 2 (Biostat Inc, Englewood NJ). The random
effects model was used. All statistical testing was two-tailed.
Results: Four randomized controlled trials from 2001
to 2008 were included, these reported on 31445 patients,
15380 were treated with ASA and 16065 with ASA/plavix.
There was no difference between the age/gender distribu-
tion among the two groups. The prevalence of diabetes,
hypertension, and history of smoking was similar (P0.05
for all comparisons). Range of treatment/follow-up period
was 9-27.6 months. The risk of stroke was lower for the
patients receiving aspirin and plavix (image 1, p  0.001).
There was a slight difference in risk of bleeding requiring
transfusion that was in favor of the ASA group (p 0.042).
Conclusions: Our meta-analysis indicates that the
combination of aspirin and plavix may be superior to aspirin
alone for prevention of stroke in patients with symptomatic
cardiovascular disease. There does appear to be slight in-
crease in risk of nonfatal bleeding with this combination.
Author Disclosures: E. Endean: Nothing to disclose; D.
Minion: WL Gore, Speaker’s bureau; S. O’Keeffe: Noth-
ing to disclose;E. Sorial: Nothing to disclose;E. S. Xenos:
Nothing to disclose.
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Hybrid Procedures for the One-stage Treatment of
Multi-focal Ipsilateral Internal Carotid and Proximal
Common Carotid/Innominate Artery Lesions
Christos Karathanos1, Georgios Antoniou1, Konstantinos
Stamoulis2, Katerina Drakou1, Georgios Vretzakis2, Atha-
nasios Giannoukas1. 1Dept. of Vascular Surgery, University
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Objectives: To report our experience with one-stage
hybrid treatment of ipsilateral proximal common carotid(CCA)/innominate and internal carotid artery (ICA) sig-
nificant stenosis.
Methods: Our vascular service offers both carotid
endarterectomy (CEA) and stenting (CAS) on specific
indications. Over the last two years (2008 - 2009) 96
carotid procedures were performed in 92 patients; 67
CEA (32 symptomatic) and 29 CAS (12 symptomatic).
Two patients with symptomatic and one with asymptom-
atic high grade (70%) ipsilateral internal and proximal
CCA stenosis were treated in one-stage with CEA and
retrograde CAS of the CCA. CEA was always performed
first and before completion of patch closure retrograde
CCA stenting was performed. ICA was clamped during
stenting. In 2 patients CEA was carried out with shunt.
All patients were under continuous electroencephalo-
graphic (EEC) monitoring.
Results: Hybrid carotid procedures for ipsilateral ca-
rotid disease were performed in three patients out of 92
(3.2%). All procedures were successfully completed. No
EEC changes were recorded. Completion angiography and
imaging one month postoperatively showed optimal stent
placement and good patency. No 30-day neurological mor-
bidity or mortality was recorded. In the one-year follow-up
all patients remained asymptomatic, recurrent ICA stenosis
50-69% in one patient and progression of a preexisting
moderate (30-49%) mid-CCA stenosis to a significant one
(70%) in another patient were detected.
Conclusions: Our experience and the literature sup-
port that one-stage CEA and retrograde CCA/innominate
artery stenting is a safe and effective procedure in those few
patients with extensive atherosclerosis of the extracranial
cerebrovascular arteries.
Author Disclosures: G. Antoniou: Nothing to disclose;
K. Drakou: Nothing to disclose;A. Giannoukas: Nothing
to disclose; C. Karathanos: Nothing to disclose; K. Sta-
moulis: Nothing to disclose; G. Vretzakis: Nothing to
disclose.
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Proximal Vertebral Artery Disease: Surgical Recon-
struction or Stenting?
Shipra Arya1, Iraklis Pipinos2, Eugene A. Waltke3, Scott P.
Wattenhofer3, Bernard T. Baxter2. 1Creighton University
Medical Center, Omaha, NE; 2University of Nebraska
Medical Center, Omaha, NE; 3Methodist Hospital,
Omaha, NE
Objectives: The origin of the vertebral artery (VA) is
a common site of atherosclerosis that may lead to poste-
rior circulation infarcts. Surgery was once the mainstay of
therapy for proximal VA disease but contemporary stud-
ies suggest interventional approaches are nowmore com-
mon. We present a case series of VA transposition in 5
patients and a systematic review of literature comparing
angioplasty/stent with surgical revascularization.
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tients (1 in 1992, 4 since 2004) underwent vertebral to
common carotid transpositions. A systematic search for all
studies that evaluated VA interventions was done through
MEDLINE and bibliographic search. Various demo-
graphic and endpoint variables were extracted.
Results: Our case series comprises 5 patients (mean age:
75.4 years, M:F 4:1, symptomatic 100%). Shunts were used in
two cases. We had no wound complications or postoperative
morbidity. The mean follow was 23.8 months with no stroke/
TIAs and100%patencyonDoppler.Onepatientdied from lung
cancer 4 years after surgery and one 6 years after surgery from
unknown causes. 30 studies on VA stenting and/or angio-
plasty were identified (1981-2009). There were 8 studies
describing surgery (1984-2000). Following surgical treat-
ment, lower rates of restenosis (2.3%) were seen with longer
follow-up, but wound complications were relatively com-
mon. Restenosis was a problem after stent placement with
no difference between bare metal (27.7%) or drug eluting
stents (26.1%). The duration of follow-up and presence of
bilateral VA disease was significantly associated with reste-
nosis on regression analysis. Unexpectedly, degree of ste-
nosis was inversely related to degree of initial stenosis.
Conclusions: Surgery and endovascular interventions
have good initial technical success. Restenosis is problem-
atic with bare metal or drug-eluting stents. Surgery is
associated with a higher risk of wound complications but
provides superior longterm results.
Author Disclosures: S. Arya: Nothing to disclose; B. T.
Baxter: Nothing to disclose; I. Pipinos: Nothing to dis-
close; E. A. Waltke: Nothing to disclose; S. P. Watten-
hofer: Nothing to disclose.
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Carotid Artery Endarterectomy (CEA) for Stroke in
Evolution (SIE): Technical and Long-term Clinical
Outcome in a Tertiary Referral Vascular Centre. When
to Master Silence?
Sherif Sultan1, Niamh Hynes2. 1Vascular & Endovascular
Surgery, Western Vascular Institute, Galway, Ireland; 2Gal-
way Clinic, Galway, Ireland
Objectives: Scheduling of CEA in symptomatic carotid
artery stenosis (SCAS) remains controversial. No consensus
exists on management of crescendo TIAs (cTIA) or SIE.
We endeavour to evaluate 5-year survival rates and freedom
from stroke in patients with SCAS14days, cTIA and SIE.
Methods: Between 2002- 2008, 1847 patients were ap-
praisedwith carotid stenosis60%.ThePredicted Probability of
Receiving intervention was tabulated for all Patients by Using
Multiple Logistic Regressions to Control for Co-morbidity and
Anatomical High-risk Factors. Mean age was similar between
SCAS, 68.6 years and cTIA, 69.1 years (p0.05) but SIE pa-
tients were younger (67.2 years) than SCAS (p  0.01) or
CTIAS (p  0.05). SVS co-morbidity scores were similar
between groups (p  0.05). SCAS were less likely to haveecholucent plaque on duplex US (p  0.001). Fast Track
Clear Pathway Permitted rapid Triage and Management.
Results: Over all Death/stroke rate was 1.9% (Table
1). Compared to SCAS (87.9%) 5-year stoke-free survival
was not distinctive for cTIA (93.3%, p  0.818) or SIE
(92.9%, p  0.184). 5-year intervention free survival was
not diverse with SCAS (87%) compared to cTIA (91.1%,
p  0.889) or SIE (92.9%, p  0.231).
Conclusions: Indications for Emergency CEA are Li-
tigious. The menace of CEA is Drastically Higher in Neu-
rologically Unstable patients. Conversely Natural History
of Acute Carotid occlusion Without Surgery is Atrocious.
Emergency Surgery should be Indicated if it Propounds
Improved Outcomes Over Aggressive Medical Therapy.
Table 1
Symptomatic
14 days
Crescendo
TIAs
Stroke in
Evolution P Value
Number 359 300 (83.5%) 45 (12.5%) 14.4%
Stroke 2 (0.67%) 1 (2.2%) 1 (7.1%) 0.059
Death 2 (0.67%) 1 (2.2%) 0 (0%) 0.533
Author Disclosures: N. Hynes: Nothing to disclose; S.
Sultan: Nothing to disclose.
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Transradial Approach for the Treatment of Non-ma-
turing Hemodialysis Fistulae May Have Better Patency
Than Standard Direct Fistula Approach
Alessandro Smeraldi, Samir Pancholy, Jason Butchko.
Community Medical Center, Scranton, PA
Objectives: Percutaneous angioplasty of non-matured
proximal arm hemodialysis arteriovenous fistulae presents a
unique challenge given the frequently non-arterialized vein
and the awkward working angle. We describe our results
using a transradial artery approach.
Methods: All patients with proximal arm fistulae who
underwent percutaneous angioplasty between July 2007 and
July 2009 were included. The primary endpoints were tech-
nical success, successful cannulation and time required for
maturation. Data were retrospectively collected and analyzed.
Results: A total of 32 consecutive procedures were
performed in 25 patients with non-maturing brachioce-
phalic or brachiobasilic fistulae. Balloon angioplasty matu-
ration was accomplished either by a radial artery approach
(RABAM) or by a standard direct fistula approach (BAM).
The RABAM study group included 14 procedures in 11
patients and the control BAM group included 18 proce-
dures in 14 patients. Patients were followed for a mean of
9.2  8.4 months. Technical success was 100% in both
groups. Four patients, two in each group, died before they
could start dialysis. Successful cannulation was achieved
more frequently in the study group (RABAM, 77.8%;
BAM, 50%). The mean time to cannulation was shorter in
the study group (RABAM, 35.7  22.7 days; BAM,
87.5  68.7 days; p 0.05). Complications were few; one
asymptomatic radial artery thrombosis and one minor he-
